ʻO Thymogen kahi immunomodulatory peptide mai ka thymus gland. Hoʻokaʻawale mua ʻia a hoʻomaʻemaʻe ʻia mai ka pipi koumus extract i ka makahiki 1970 mua, kona inoa ʻo 'Thymogen’ hōʻike i kāna hana mua – hooikaika ana i ka ʻokoʻa o nā pūnaewele pre-T i nā ʻano hana like ʻole nā pūʻali T.
Pākuʻi lāʻau immunological No laila he hoʻohana maikaʻi ʻia no kēia peptide.
Kaʻina
Glu-Trp
Helu CAS
/
ʻĀpana Molekala
C16H19N3O5
Kaumaha Molekala
333.344
Noi'i no Thymogen Peptide
1.Mechanism of Action
ʻO ka hana kūpono a pololei i loko o ka hoʻonui ʻana a me ka hoʻomaʻamaʻa hana hope o kēia mau mea lymphocytes ʻo ia kekahi o kāna mau waiwai nui. Hoʻomoe nā hormones thymic’ Hoʻonui ʻia ka hana olaola e Thymogen; ka launa pū ʻana me nā ala hōʻailona o lalo, Hoʻoikaika ka peptide i ka synthesis a me ka liʻiliʻi o ka huna ʻana o ka mea nui cytokines (IL-2 he kumu hoohalike), a me ka hoʻoponopono ʻana i nā mea hoʻokipa kiʻekiʻe IL-2.
2.Nā noi lāʻau lapaʻau
Hoʻohana pololei ka hoʻohana ʻana i ka lāʻau lapaʻau o Thymogen i ke kino o ke kino antiviral a me ka anti-intracellular pathogen hiki.; ʻoi aku ka maikaʻi o ka nānā ʻana i ka pale ʻana a me ka hoʻomaʻemaʻe ʻana o kekahi mau mea ʻokoʻa he ʻelua mau hopena i makemake ʻia.
ʻO ka hoʻemi ʻana i nā helu kelepona T kikoʻī a i ʻole ka hana ʻino i nā ʻano like ʻole immunodeficiency hiki ke hoʻoponopono ʻia nā mokuʻāina. Hoʻihoʻi hou i ka Th1/Th2 koena ʻo ia kekahi ʻāpana o kona hiki ke hoʻomaʻamaʻa.
3.T Hoʻomohala ʻana i nā Lymphocyte
Hoʻolaha (a me ka mālama ʻana) T lymphocyte ulu, ʻokoʻa a me nā ʻano pili āpau o ka oʻo: Hoʻohālike i ka microenvironment thymic maoli, Hana pololei ʻo Thymogen ma ka 'core’ o ke kino kino.
ʻO ka hoʻopaʻa paʻa ʻana i nā cell target i ukali ʻia e ka hōʻailona intracellular ka mea e hoʻokau i kēia kaʻina hana.
ʻO nā subset cell T oo ka huahana hope, ʻO ka nui o ka loko wai maʻamau a me ka hana ʻo ia ke kūlana hope loa o ka hoʻoponopono e pono ai ke kino.
ʻO ka hoʻohaʻahaʻa ʻana o ka immune e pili ana i ka ʻelemakule kekahi o nā pilikia koʻikoʻi koʻikoʻi i hāʻawi ʻia e Thymogen i kahi pae kōkua maoli a hiki ke ana..
4.Anti-infective Immunity
Hoʻonui nā pane ʻana o ke kino a me nā mana anti-infection: Hoʻonui nui ʻo Thymogen i ka maikaʻi o ka pane ʻana o ke kino.
I ka hoʻouka ʻana o ka pathogen, Hoʻoikaika ikaika ʻo Thymogen i nā cell T e hūnā i nā cytokines kī; pololei phagocytosis a ʻo ka pepehi ʻana i nā pathogens e kōkua nui ʻia e kēia mau mea.
Hōʻike nā noi lapaʻau o Thymogen i ka hoʻomaikaʻi maikaʻi ʻana i ka pale o ke kino i nā maʻi maʻi mau a me nā maʻi hou, ka hoopokole ana i ke ala o ia mau ma'i, e hoemi ana i ka pinepine o ka hana hou ana; ʻO nā mea maʻi i hoʻonāwaliwali i ka hana palekana e pōmaikaʻi loa mai kēia ʻano kikoʻī o kāna hana.
5.Pākuʻi ʻAi-Tumor Effects
Hiki i ka Thymogen ke hoʻonui nui Kelepona T Cytotoxic / CTL ka hana a me ka hoonui, pili nā mea a pau me ka hana cytokine kikoʻī (IFN-γ he kumu hoohalike).
ʻO ka ʻike ʻana a me ka hoʻopau ʻana i nā cell tumor kahi ʻāpana o ka hana mua o ka ʻōnaehana pale kino innate/adaptive., ka nānā ʻana i ke kino ʻo ia ka ʻōlelo pololei loa i hoʻohana ʻia.
ʻO ka radiotherapy a me ka chemotherapy e hōʻino i ka hematopoietic a me nā ʻōnaehana pale i kekahi ʻano; ʻO ka hoʻopaʻa ʻana ma hope o ka mālama ʻana he hopena ʻaoʻao.
ʻO ka hoʻohana ʻana o Thymogen i kēia pōʻaiapili e kōkua i ke kino o ka mea maʻi e hoʻihoʻi hou i ka hana pale mai ka ʻino, nā maʻi like ʻole e hoʻemi ʻia, maikaʻi ka maikaʻi o ke ola.
COA
HPLC
MS





